reata pharmaceuticals inc stock price

Saturday, November 12, 2022 Edit

Shares of RETA opened at 4205 on. 91 rows Sep 19.

Plano Based Drug Developer Reata Raises 505 Million Expects To Double To 400 Employees By End Of 2020

Get the latest Reata Pharmaceuticals Inc.

. Reata Pharmaceuticals Inc. Sep 2017 2018 2019 2020 2021 2022 10 20 30 40 50 0 2M 4M 6M 8M. Reata Pharmaceuticals Inc.

Know When To Sell Your Stocks. Ad Our Strong Buys Double the SP. View the latest Reata Pharmaceuticals Inc.

Reata Pharmaceuticals price target raised to 50 from 43 at Barclays November 9. Reata Pharmaceuticals Inc. RETA came out with a quarterly loss of 216 per.

Find real-time RETA - Reata Pharmaceuticals Inc stock quotes company profile news and. Discover the Power of thinkorswim Today. Reata Pharmaceuticals Trading Up 114.

NASDAQRETA price on Thursday November 10. A high-level overview of Reata Pharmaceuticals Inc. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

View the latest Reata Pharmaceuticals Inc. Cl A RETA stock price news historical charts. The companys Stock price change every day as a result of market forces.

Choose Investments Using 0 Online Stock and ETF Trades. November 9 2022. Based On Fundamental Analysis.

RETA stock price news buy or sell. Not an offer or recommendation by Stocktwits. Stock analysis for Reata Pharmaceuticals Inc RETANASDAQ GM including stock price stock.

Class A Common Stock RETA Stock Quotes - Nasdaq offers. View Reata Pharmaceuticals Inc RETA investment stock information. Based On Fundamental Analysis.

3rd Party Ad. RETA - Free Report reported. Cl A RETA stock price news historical charts.

NASDAQRETA may have lost US207m in value but insiders who. For the readers interested in the stock health of Reata. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease.

Reatas development programs have created a robust pipeline of drug candidates. 7 brokers have issued 12-month target prices for Reata Pharmaceuticals stock. Ad Build Your Portfolio Your Way.

Reata Pharma Announces 350 Million Strategic Investment From Blackstone Life Sciences

Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S

Reata Pharmaceuticals Inc Announces Fourth Quarter And Full Year 2021 Financial Results And Provides An Update On Clinical Development Programs Business Wire